Company Profile
Updated: 09-OCT-09Targacept Inc.
Public Company, Headquarters Location
200 E First St., Ste. 300, Winston-Salem, NC 27101-4165, United States
(336)480-2100, (336)480-2107 fax, http://www.targacept.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Bio-Pharmaceuticals. Services: Drug research and development.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
UNIVERSITY OF SOUTH FLORIDA-PATENTED DRUG CENTER OF MAJOR DEAL
US Fed News Service, Including US State News; 12/8/2009; 964 words; ...pharmaceutical company AstraZeneca PLC and Targacept, Inc., potentially earning the university...On Thursday, AstraZeneca and Targacept announced a collaboration and license...will make an upfront payment to Targacept of $200 million upon effectiveness...
Other News To Note.
BIOWORLD Today; 12/7/2009; 1188 words; o Allos Therapeutics Inc., of Westminster, Colo., has signed...from Winston-Salem, N.C.-based Targacept Inc. AstraZeneca licensed rights to TC...2009.) o Chaperone Technologies Inc., of East Stroudsburg, Pa., and...
AstraZeneca drug wins partial US approval
AP Worldstream; 12/4/2009; 551 words; ...after AstraZeneca announced a deal to develop a depression drug with Targacept Inc. AstraZeneca is paying Targacept $200 million upfront upon effectiveness of TC-5214, Targacept's late-stage investigational treatment for MDD. AstraZeneca...
Moody Market Clips Targacept Despite Major Depression Deal.
BIOWORLD Today; 12/4/2009; 1406 words; ...depression candidate TC-5214 with Targacept Inc. gives AstraZeneca plc backup...Winston-Salem, N.C.-based Targacept's shares (NASDAQ:TRGT) closed...meaningful catalysts" lies ahead of Targacept, too, as Leerink Swann analyst...
Targacept, AstraZeneca cooperate on depression med
AP Online; 12/3/2009; 722 words; Targacept Inc. on Thursday struck a deal potentially worth more...Under terms of the agreement, AstraZeneca will pay Targacept $200 million upfront upon effectiveness of TC-5214, Targacept's late-stage investigational treatment for major...
Recent News Articles
- Mintz Levin Represents Targacept Inc. in Public Offering.
Biotech Week - November 04, 2009 - Penny Stock Chaser Announces Investment Opinion on Gannett Co. Inc., MGM Mirage, Alcatel-Lucent, Targacept and Ford Motor Co.
Business Wire - July 15, 2009 - FDA Calendar and News Updates for Elan Corporation (NYSE: ELN), Targacept (NASDAQ: TRGT), CytoDyn (OTC: CYDY) and Affymetrix, Inc. (Nasdaq:AFFX).
M2 Presswire - July 09, 2009 - Targacept Inc., Dissected.
M2 Presswire - July 09, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning